Xynova 2% Injection Lidocaine (2%)

About this Medicine

Xynova 2% Injection Lidocaine is a critical pharmaceutical product, manufactured by Troikaa Pharmaceuticals, designed to deliver effective local anesthesia and manage specific cardiac arrhythmias. This sterile solution contains 2% Lidocaine (also known as Lignocaine), a well-established medication that functions as both a local anesthetic and an antiarrhythmic agent. As a local anesthetic, Xynova 2% works by temporarily blocking nerve impulses in a specific area of the body. This prevents pain signals from reaching the brain, providing targeted pain relief during minor surgical procedures, dental work, diagnostic procedures, and other medical interventions where localized pain control is essential. Beyond its anesthetic properties, Xynova 2% Injection also serves a vital role in cardiology. It is indicated for the treatment of acute ventricular arrhythmias, particularly those occurring during or immediately after myocardial infarction, or in the context of cardiac surgery and digitalis intoxication. In these instances, Lidocaine stabilizes the heart muscle cells, reducing abnormal electrical activity that can lead to dangerous irregular heartbeats. Administered by healthcare professionals, Xynova 2% Lidocaine ensures patient comfort and safety during various medical procedures. Its rapid onset of action allows for quick pain management, while its controlled application helps minimize discomfort without affecting consciousness. Patients undergoing minor surgeries, suture placements, biopsies, or dental extractions can benefit significantly from its localized numbing effect. For its antiarrhythmic use, the precise administration and monitoring by medical staff are paramount to manage complex cardiac conditions effectively. Always consult with a healthcare professional to determine if Xynova 2% Injection is appropriate for your specific medical needs.